![3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol](https://static.cymitquimica.com/products/3D/img/WZB18779.png "Clique para ampliar")
Informação sobre produto
3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is a compound that has been shown to lower blood glucose levels in animal models and has potent oral efficacy, as well as agonistic activity at the GLP-1 receptor. It is currently in phase II clinical trials for the treatment of type 2 diabetes. 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is an orally active compound that lowers glucose levels by stimulating insulin secretion and enhancing insulin sensitivity in liver cells. It has been shown to have a conformationally restricted agonist activity at the GLP-1 receptor, which may be due to its structural similarity to octane, a ligand for this receptor
Propriedades químicas
Consulta técnica sobre: 3D-WZB18779 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
